Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine in Idiopathic Restless Leg Syndrome
NCT00243217Phase 2Completed
- Sponsor
- UCB
- Start
- Apr 2003
- Primary completion
- Feb 2004
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Primary endpoint: International RLS Study Group Rating Scale. Started Apr 2003; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00243217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243217.